# Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes

> **NCT02325466** · PHASE3 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 70 (actual)

## Conditions studied

- Peripheral Artery Disease
- Type 2 Diabetes

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Ticagrelor
- **DRUG:** Aspirin Placebo
- **DRUG:** Ticagrelor Placebo

## Key facts

- **NCT ID:** NCT02325466
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2018-05-04
- **Final completion:** 2018-05-04
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2022-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02325466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02325466, "Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02325466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*